WorldWide IVD Diabetes Products Quarterly Review
The worldwide IVD Diabetes Products Quarterly Review is BBC's most up-to-date review of the market and includes an analysis of the quarterly performances of the major IVD diabetology and insulin/insulin delivery competitors, as well as emerging secondary manufacturers of Whole Blood Glucose (WBG), Non-Invasive Glucose Monitoring products (NIGM), and Continuous Glucose Monitoring Systems (CGMS). The report, along with e-mail alerts and a market note with initial performance estimates (published within five weeks after the quarter closes) enables clients to keep abreast of new product information, identify trends, and assess competitors' strengths and weaknesses for short-term decision making.
In addition to tracking quarterly IVD industry performances by company (U.S. versus international), the report provides a summary review of worldwide, U.S., Japan, and individual Europe and ROW country markets for diabetes-related IVD market changes and noteworthy industry efforts. The consultants carefully monitor reimbursement changes, educational efforts, and pricing in all of the key international markets including Asia Pacific and Latin America.
Additional report details include:
- A review of diabetes-related product promotions at major U.S. and international conventions, including the AACC, ADA, AADE, DDG, EASD, and MEDICA
- Quarterly worldwide, U.S., and international revenue and revenue growth estimates for the "Top Three" insulin infusion pump competitors (Medtronic MiniMed, Roche Disetronic, and Animas)
- Discussion of secondary insulin infusion pump competitors (e.g., Smiths Medical, Insulet)
- Quarterly and year-end revenue and growth estimates for the "Top Three" insulin companies (Novo Nordisk, Eli Lilly, Sanofi-Aventis). The report includes a discussion of quarterly competitive activities and performances as well as updates in R&D activities. Revenue and updates relating to the launch of Pfizer's inhaleable insulin product (Exubera®) are also included
- Quarterly worldwide, U.S., and international revenue estimates and discussion of business development activities in the area of CGMS.
The report contains a "year-end" outlook section that provides the client with a near-term outlook for individual WBG product competitors and specific country markets.